4D Molecular Therapeutics (FDMT) Interest & Investment Income (2020 - 2025)
Historic Interest & Investment Income for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to $4.3 million.
- 4D Molecular Therapeutics' Interest & Investment Income fell 4060.36% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year decrease of 1492.21%. This contributed to the annual value of $27.0 million for FY2024, which is 12152.16% up from last year.
- Latest data reveals that 4D Molecular Therapeutics reported Interest & Investment Income of $4.3 million as of Q3 2025, which was down 4060.36% from $4.9 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Interest & Investment Income registered a high of $7.5 million during Q2 2024, and its lowest value of -$312000.0 during Q4 2021.
- Moreover, its 5-year median value for Interest & Investment Income was $2.5 million (2023), whereas its average is $3.0 million.
- Within the past 5 years, the most significant YoY rise in 4D Molecular Therapeutics' Interest & Investment Income was 1077500.0% (2021), while the steepest drop was 790000.0% (2021).
- Quarter analysis of 5 years shows 4D Molecular Therapeutics' Interest & Investment Income stood at -$312000.0 in 2021, then surged by 528.85% to $1.3 million in 2022, then soared by 227.35% to $4.4 million in 2023, then soared by 47.65% to $6.5 million in 2024, then crashed by 33.04% to $4.3 million in 2025.
- Its Interest & Investment Income was $4.3 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.6 million in Q1 2025.